0000912282-24-000006.txt : 20240102 0000912282-24-000006.hdr.sgml : 20240102 20240102163759 ACCESSION NUMBER: 0000912282-24-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240102 DATE AS OF CHANGE: 20240102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PYSZCZYMUKA GREG CENTRAL INDEX KEY: 0001952920 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38247 FILM NUMBER: 24503029 MAIL ADDRESS: STREET 1: C/O AYTU BIOPHARMA, INC. STREET 2: 373 INVERNESS PARKWAY, SUITE 206 CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER NAME: FORMER CONFORMED NAME: PYSZCAYMUKA GREG DATE OF NAME CHANGE: 20221031 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AYTU BIOPHARMA, INC CENTRAL INDEX KEY: 0001385818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 470883144 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 7900 E. UNION AVENUE STREET 2: SUITE 920 CITY: DENVER STATE: CO ZIP: 80237 BUSINESS PHONE: (720) 437-6580 MAIL ADDRESS: STREET 1: 7900 E. UNION AVENUE STREET 2: SUITE 920 CITY: DENVER STATE: CO ZIP: 80237 FORMER COMPANY: FORMER CONFORMED NAME: AYTU BIOSCIENCE, INC DATE OF NAME CHANGE: 20150609 FORMER COMPANY: FORMER CONFORMED NAME: AYTU BIOSCIENCE, INC. DATE OF NAME CHANGE: 20150609 FORMER COMPANY: FORMER CONFORMED NAME: Rosewind CORP DATE OF NAME CHANGE: 20070110 4 1 form4.xml X0508 4 2023-12-31 0001385818 AYTU BIOPHARMA, INC AYTU 0001952920 PYSZCZYMUKA GREG C/O AYTU BIOPHARMA, INC. 7900 E. UNION AVENUE, SUITE 920 DENVER CO 80237 true Chief Commercial Officer false Common Shares 2023-12-31 4 M 0 209 A 22560 D Restricted Stock Units 2023-12-31 4 M 0 209 0 D Common Shares 209 1042 D Represents restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted on March 31, 2022, and vest as follows: One-third on March 31, 2023; 1/12th of the original grant quarterly thereafter through March 31, 2025. Settlement of vested RSUs will occur as soon as practicable following vesting. /s/ Mark Oki as attorney-in-fact for Greg Pyszczymuka 2024-01-02